Fervent Synergies' Stock Hits 52-Week Low, Declines by -2.99% Amidst Negative Performance
Fervent Synergies, a microcap pharmaceutical company, has hit a 52-week low with its stock price dropping to Rs.14.6 on May 17, 2024. According to financial analysis platform MarketsMojo, the stock is currently a 'Strong Sell' due to trading below its moving averages. The company's negative 1-year performance highlights its struggles in the market.
Fervent Synergies, a microcap pharmaceutical company, has recently hit a 52-week low with its stock price dropping to Rs.14.6 on May 17, 2024. This decline in stock price has been reflected in the company's overall performance today, with it underperforming the sector by -2.99%.
According to MarketsMOJO, a leading financial analysis platform, Fervent Synergies' stock call is currently a 'Strong Sell'. This is due to the fact that the company's stock is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a downward trend in the stock's performance.
In comparison to the Sensex, Fervent Synergies has had a negative 1-year performance of -18.44%, while the Sensex has seen a positive performance of 20.08%. This further highlights the company's struggles in the market.
While there has been no mention of investor interest or expert opinions, it is clear that Fervent Synergies is facing challenges in the pharmaceutical industry. As a microcap company, it may be more susceptible to market fluctuations and competition. Investors and stakeholders should keep a close eye on the company's performance in the coming months.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
